Current Projects
-
SCRIPT Trial: A Randomised Controlled Trial utilising a genomic test as an intervention providing personalised bowel cancer screening information
-
MAGPIE Study: A genomic test intervention designed to provide patients with personalised melanoma, bowel, breast, and prostate cancer screening information
-
PRESIDE Trial: A Randomised Controlled Trial providing antidepressant medication information to patients with mild-to-severe depressive symptoms.
-
SMARTERScreen: A Randomised Controlled Trial based on evidence from SMARTScreen utilising SMS messages to prompt patients overdue with bowel cancer screening
-
IC3 Trial: A Randomised Control Trial aiming to improve early diagnosis of liver cancer and improving patient health outcomes
-
Future Health Today: A randomised control trial of pharmacological therapies to reduce cardiovascular risk in people with chronic kidney disease and investigation of people at increased risk of cancer
-
CANARY (CANcer risk in patients with unexpected weight loss in primaRY care) Studies: Clinical Decision Support Systems for Cancer Prevention and Early Cancer Detection in Primary Care
-
The Data Connect Program: Linking primary care, hospitals and cancer registry data to study the cancer continuum of care.
-
The IDEAL Care Trial: IDEntifying Advanced Liver Fibrosis in Primary Care
-
The CASSOWARY Trial: A Randomised Controlled Trial of the clinical utility and cost-effectiveness of a multi-cancer polygenic risk score in general practice
-
ROSELLA Study: Implementation of risk-stratified population screening for Australia’s most common cancers
-
RoBiN (Risk of Breast Neoplasia): An acceptability and feasibility study of personalised screening